# Safety and Preliminary Efficacy of Anti-CDH17 CAR-T Cell Therapy in Patients with CDH17-positive Advanced Solid Tumors

> **NCT06820424** · EARLY_PHASE1 · RECRUITING · sponsor: **920th Hospital of Joint Logistics Support Force of People's Liberation Army of China** · enrollment: 30 (estimated)

## Conditions studied

- CDH17-positive Advanced Solid Tumors

## Interventions

- **BIOLOGICAL:** Anti-CDH17 CAR-T cells infusion

## Key facts

- **NCT ID:** NCT06820424
- **Lead sponsor:** 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03
- **Primary completion:** 2028-01
- **Final completion:** 2028-06
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-02-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06820424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06820424, "Safety and Preliminary Efficacy of Anti-CDH17 CAR-T Cell Therapy in Patients with CDH17-positive Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT06820424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*